November 12, 2020
Webinar
Association of Corporate Counsel (ACC)
All new and useful inventions or discoveries are not eligible for patenting—the subject matter of the claimed invention must fall within the boundaries set forth in 35 U.S.C. § 101, which exempts innovations directed to laws of nature, natural phenomena, or abstract ideas (unless the claim includes additional limitations amounting to significantly more than the exempted subject matter). Section 101 concerns reach most of today’s technology, including medical devices, diagnostics, software-related technology such as AI, machine learning, and robotics, and even pharmaceutical treatments.
We will discuss concerns relevant to protecting your company’s products/services and evaluating the portfolios of others. We will also discuss how district courts are handling Section 101 challenges at both the motion to dismiss stage and at summary judgment, and provide an overview of emerging trends in Section 101 motions. To round out the discussion, corporate counsel from the life sciences and tech industries will share their insight on how these Section 101 issues are impacting their businesses.
Please join us as we address:
Moderator:
Ming Yang, Finnegan
Speakers:
Paul Barker, Finnegan
Aaron Capron, Finnegan
Robert McCauley, Finnegan
35 U.S.C. § 101, inventorship, subject matter eligibility, United States Court of Appeals for the Federal Circuit (CAFC), United States Patent and Trademark Office (USPTO)
June 10-12, 2024
San Francisco
Lecture
Patent Protection for Software-Related Inventions in Europe and the USA Training Course
June 5, 2024
Hybrid
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.